Max Meehan

Max Meehan (he/him)Board Member

Max Meehan works at the intersection of finance, biotech, and entrepreneurship. Max is VP of Corporate Development & Finance at Windgap Medical, an innovative drug delivery company. Previously, he was a member of the investment team at Altaris Capital Partners, where he executed investments in the biopharma industry. Max began his career in the healthcare practice at Bain & Company in New York. In addition to OUTbio, Max is on the Advisory Board of the Rubin Museum of Himalayan Art. He also advises safety-net hospitals on regulatory, financial, and health policy issues.

Max holds an MBA from Harvard Business School, as well as an MA in biotechnology and an AB in chemistry and chemical biology from Harvard University.